Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)

  • Kai Uwe Lewandrowski
  • , Kenneth Blum
  • , Alexander P.L. Lewandrowski
  • , Panayotis K. Thanos
  • , Albert Pinhasov
  • , Alireza Sharafshah
  • , David Baron
  • , Mark S. Gold
  • , Catherine A. Dennen
  • , Igor Elman
  • , Aballa Bowirrat
  • , Edward J. Modestino
  • , Foojan Zeine
  • , Nicole Jafari
  • , Keerthy Sunder
  • , Milan T. Makale
  • , John Giordano
  • , Marjorie C. Gondre-Lewis
  • , Marco Lindenau
  • , Brian S. Fuehrlein
  • Rajendra D. Badgaiyan, Chynna Levin, Sergio Luis Schmidt, Rossano Kepler Alvim Fiorelli

Research output: Contribution to journalComment/debate

Abstract

Substance Use Disorders and Behavioral Addictions The title of this article was erroneously given as “Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying genetic/epigenetic predisposition to hypodopaminergia.” The correct title of the article is “Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.” The original version of this article has been updated.

Original languageEnglish
Article number1737084
JournalFrontiers in Public Health
Volume13
DOIs
StatePublished - 2025

Keywords

  • Reward Deficiency Syndrome (RDS)
  • addiction and mood disorders
  • dopamine D2 receptor (DRD2)
  • genetic predisposition
  • hypodopaminergia
  • neurotransmitter regulation
  • pro-dopaminergic therapy
  • stress induced anxiety

Fingerprint

Dive into the research topics of 'Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)'. Together they form a unique fingerprint.

Cite this